Abivax (ABVX) Cash from Operations (2024 - 2025)
Abivax (ABVX) recorded quarterly Cash from Operations of 27004645.5 in Q4 2025, up 67.59% quarter-over-quarter from 83333754.08 in Q3 2025, and up 24.66% on a YoY basis from 21662958.62 in Q4 2024.
Abivax (ABVX) Cash from Operations (2024 - 2025) Analysis & Trends
Abivax's Cash from Operations history runs 2 years deep, the most recent figure standing at 27004645.5 for Q4 2025.
- In Q4 2025, Cash from Operations rose 24.66% year-over-year to 27004645.5; the TTM figure through Dec 2025 stood at 183082545.95 (down 9.79% YoY), while the FY2025 annual figure was 187527410.22, down 13.88% from the prior year.
- Cash from Operations was 27004645.5 for Q4 2025 at Abivax, up from 83333754.08 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 27004645.5 in Q4 2025 to a low of 83333754.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.00 Mn |
| Dec 31, 2025 | -27.00 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Mar 31, 2024 | -37.76 Mn |
| Mar 31, 2024 | -37.76 Mn |